[Influence of tumor necrosis alpha blockade with infliximab on lipid profile in patients with active rheumatoid arthritis]

Med Clin (Barc). 2006 May 20;126(19):757. doi: 10.1157/13088951.
[Article in Spanish]
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / pharmacology*
  • Arthritis, Rheumatoid / drug therapy*
  • Cholesterol, HDL / metabolism*
  • Cholesterol, LDL / metabolism*
  • Female
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Prospective Studies
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Tumor Necrosis Factor-alpha
  • Infliximab